2017 was an historic year for the Canadian Cancer Society (CCS) marked by our bold steps to address challenges, build on successes and innovate for the future. Most notably, in February 2017, we joined forces with the Canadian Breast Cancer Foundation, bringing together two of the largest national health charities in an unprecedented merger.
While these steps weren’t easy, they were critically important to ensure we were using donor dollars to have the greatest impact.
Because of these steps, we have transformed as an organization. The financials for 2017/18 reflect the tremendous efforts that were made to ensure we are a stronger organization, better able to have a deeper, more meaningful impact on cancer in Canada.
Read our national financial statements:
Information about our T3010
Charities are legally required to file a Registered Charity Information Return (T3010) to the Canada Revenue Agency (CRA). It discloses financial information including the CCS’s programs, fundraising activities and executive compensation. As of February 1, 2015, the CCS’s internal provincial divisions and the national office have amalgamated their business numbers under the Canada Revenue Agency. As a result, CRA no longer provides access to the regions’ separate T3010. Read our most recent T3010.
Our Impact Reports
Read our annual reports and find out how we’re making a meaningful difference to Canadians.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.